Market Cap 113.47M
Revenue (ttm) 31.08M
Net Income (ttm) -200.40M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -644.79%
Debt to Equity Ratio 0.69
Volume 27,309,199
Avg Vol 16,596,061
Day's Range N/A - N/A
Shares Out 246.24M
Stochastic %K 37%
Beta 1.04
Analysts Sell
Price Target $2.60

Latest News on LXRX

Lexicon Appoints Scott Coiante as Chief Financial Officer

Jan 2, 2025, 8:00 AM EST - 3 months ago

Lexicon Appoints Scott Coiante as Chief Financial Officer


US FDA declines to approve Lexicon Pharma's add-on diabetes drug

Dec 20, 2024, 4:46 PM EST - 3 months ago

US FDA declines to approve Lexicon Pharma's add-on diabetes drug


Lexicon Appoints Ivan H. Cheung to Board of Directors

Nov 20, 2024, 4:05 PM EST - 4 months ago

Lexicon Appoints Ivan H. Cheung to Board of Directors


Lexicon Pharmaceuticals to Host 2024 Investor Day

Apr 18, 2024, 8:00 AM EDT - 1 year ago

Lexicon Pharmaceuticals to Host 2024 Investor Day